HDA Research Foundation honors Craig Cowman of Cardinal Health With Nexus Award
Presented annually since 1956, the Nexus Award is the healthcare distribution industry鈥檚 highest individual achievement.
HDA
Americares honors Teva with Power of Partnership Award
The award honors HDA members for exceptional commitment to enhancing global healthcare accessibility.
HDA鈥檚 PCSC honors supply chain security leaders
The awards celebrate professionals who have shown exemplary dedication to protecting the integrity of the supply chain and upholding the highest standards of safety and security in both public and private sectors.
PCSC expands GDP Program with addition of four accredited companies
The Good Distribution Practices Accreditation Program aims to support pharmaceutical supply chain stakeholders, especially vendor service providers, in demonstrating compliance with globally recognized GDP operational and training standards.
Video Forum: Jody Hatcher, HDA
Healthcare Distribution Alliance chairman on what lies ahead.
HDA gives 2025 Distribution Management Award to Cencora, Dispensary of Hope and Viatris
Winning companies are selected by the distributor and manufacturer member executives of the HDA Industry Relations Council.
HDA presents Cencora鈥檚 Matt Sample with DMA for industry leadership
鈥淢att's leadership, dedication to innovation and commitment to excellence have made him a standout in the healthcare distribution industry."
Three health care distribution industry trends to watch
The latest Factbook reveals that approximately 95 percent of all pharmaceutical sales moved through the traditional distribution segment in 2023, among other key findings.
HDA convenes supply chain experts and patient advocates to examine drug shortages solutions
HDA recently hosted a聽LinkedIn Live discussion聽exploring how supply chain stakeholders are working together to tackle these challenges and advocate for solutions.
HDA Factbook: Rx sales through traditional health care distributors remain strong in 2023
Pharmaceutical distributor sales reached $758 billion amid some of the lowest profit margins in the study鈥檚 95-year history 鈥� 0.3 percent (net after taxes) and 1.7 percent (gross) in 2023.
HDA issues statement on FDA鈥檚 phased exemption for eligible trading partners from the DSCSA鈥檚 final implementation requirements
鈥淗DA and our pharmaceutical distributor members applaud the FDA鈥檚 decision to grant an exemption for the DSCSA鈥檚 enhanced drug distribution security (EDDS) requirements for eligible trading partners."